Quantum-Si (QSIAW)
undefined
undefined%
At close: undefined
0.50
19.05%
After-hours Dec 13, 2024, 05:56 PM EST

Company Description

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.

The company was founded in 2013 is headquartered in Branford, Connecticut.

Quantum-Si
Quantum-Si logo
Country United States
IPO Date n/a
Industry Biotechnology
Sector Healthcare
Employees 159
CEO Jeffrey Alan Hawkins

Contact Details

Address:
29 Business Park Drive
Branford,
United States
Website https://www.quantum-si.com

Stock Details

Ticker Symbol QSIAW
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001816431
CUSIP Number n/a
ISIN Number US74765K1135
Employer ID 85-1388175
SIC Code 3829

Key Executives

Name Position
Jeffrey Alan Hawkins President, Chief Executive Officer & Director
Jeffry R. Keyes CPA Chief Financial Officer & Treasurer
Todd Rearick Chief Technology Officer
Alex A. Hutcheson Senior Vice President of Sales & Service
Dr. Christian Lapointe J.D., Ph.D. General Counsel & Corporate Secretary
Dr. Jonathan M. Rothberg Ph.D. Founder & Executive Director
Johan Denecke Senior Vice President of Operations
John S. Vieceli Chief Product Officer
Juan Esteban Avendano Vice President of Investor Relations
Katherine Atkinson Senior Vice President of Demand Generation & Corporate Brand

Latest SEC Filings

Date Type Title
Dec 11, 2024 8-K Current Report
Dec 11, 2024 424B5 Filing
Dec 09, 2024 8-K Current Report
Nov 22, 2024 8-K Current Report
Nov 21, 2024 8-K Current Report
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K/A [Amend] Current Report
Nov 08, 2024 8-K Current Report
Sep 25, 2024 4 Filing
Sep 18, 2024 4 Filing